Table 1. Patients’ demographics.
| Number (%) (neoadjuvant chemotherapy group) | Number (%) (primary surgery group) | |
|---|---|---|
| Total number of patients | 103 | 142 |
| Median age | 63 years | 74 years |
| Sex | ||
| Male | 83 (81%) | 105 (73.9%) |
| Female | 20 (19%) | 37 (26%) |
| T stage | ||
| T1 | 4 (3.8%) | 14 (9.8%) |
| T2 | 24 (23.6) | 48 (33.8%) |
| T3 | 64 (62%) | 75 (52.8%) |
| T4 | 9 (8.6%) | 5 (3.5%) |
| TX | 2 (2%) | |
| N stage | ||
| N0 | 29 (28%) | 33 (23.2%) |
| ⩾N1 | 74 (72%) | 109 (76.8%) |
| M stage | ||
| M0 | 103 (100%) | 140 (98.5%) |
| M1 | — | 2 (1.4%) |
| Tumour type | ||
| Adenocarcinoma | 88 (85.4%) | 142 (100%) |
| Squamous cell carcinoma | 13 (12.6%) | — |
| Adenosquamous | 2 (1.9%) | — |
| Site of tumour | ||
| Gastric | 20 (19.4%) | 142 (100%) |
| GOJ | 47 (45.6%) | — |
| Lower third of oesophagus | 36 (35%) | — |
| Surgery | ||
| Total gastrectomy | 22 | 70 |
| Partial gastrectomy | 5 | 52 |
| Oesophagectomy/oesophago- gastrectomy | 76 | 20 |
| TRG response after chemotherapy | ||
| 1, 2 and 3 | 43 (41.7%) | — |
| 4 and 5 | 60 (58.3%) | — |
| Survival status | ||
| Alive | 47 (46%) | 54 (38%) |
| Dead | 56 (54%) | 87 (62%) |
Abbreviations: GOJ=gastro-oesophageal junction; TRG=tumour regression grade.